• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Gene therapy of gastrointestinal cancer using adenoviral vector

Research Project

Project/Area Number 07671380
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionNagoya University

Principal Investigator

AKIYAMA Seiji  Nagoya University School of Medicine, Second Department of Surgery, Assistant professor, 医学部, 助手 (40202551)

Co-Investigator(Kenkyū-buntansha) ISOBE Ken-ichi  Nagoya University School of Medicine, Department of Immunology, Associate profes, 医学部, 助教授 (20151441)
TAKESHITA Hiroki  Nagoya University School of Medicine, Second Department of Surgery, Research ass, 医学部, 医員
SEKIGUCHI Hiroyuki  Nagoya University School of Medicine, Second Department of Surgery, Research ass, 医学部, 医員
Project Period (FY) 1995 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥2,400,000 (Direct Cost: ¥2,400,000)
Fiscal Year 1996: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1995: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywordsadenovirus / gastrointestinal cancer / gene therapy / 細胞性免疫
Research Abstract

The possibility of using adenoviruses for gene therapy of gastrointestinal cancer was investigated. First, a lacZ gene with an inserted adenovirus (AxlacZ) was used as a reporter gene for in vitro and in vivo infection experiments. Cultured cell strains from esophageal, stomach, and large intestinal cancers were placed in contact with AxlacZ in vitro, and the adenovirus infectivity was examined using X-gal stain. A considerable difference in infectivity was seen between the cell strains, varying from about 20% to nearly 100%. Next, the cell line was implanted subcutaneously in nude mice, AxlacZ was injected directly into the tumor, and several days later the tumor was excised. It was then stained with X-gal, and the adenovirus infection was confirmed. In addition, cellular immunity from the adenovirus was investigated using BALB/c mice and large intestinal cancer cell line colon 26 from them. AxlacZ was first administered into the mouse abdominal cavity, and afterward colon 26 infected … More with AxlacZ was implanted into the mice. Tumor growth was suppressed compared to when no AxlacZ pre-treatment was given, suggesting establishment of cellular immunity.
Next, recombinant adenovirus (Axp53) expressing wild-type p53 was prepared, and used to investigated the antitumoral effect in the esophageal cancer cell line in vitro and in vivo. The cell line was infected with Axp53 in vitro and cell survival was examined in an MTT assay. A variation of about 20% to 90% was seen, depending on the cell line. In the in vivo investigation, the cell line was implanted subcutancously in nude mice, and AxlacZ or Axp53 was injected directly. Suppression of cell proliferation was seen with AxlacZ,but Axp53 proved to be even more effective. In the region of the Axp53 injection p53 protein expression was confirmed by immunostaining. The combination of Axp53 with an anticancer agent was also investigated both in vitro and in vivo, but only an additive effect was obtained.
In light of the foregoing, p53 recombinant adenovirus is seen to be an effective gene therapy for gastrointestinal cancer. Less

Report

(3 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Hroyuki, Sekiguchi: "Efficient adenovirus-mediated gene transter into human cancer cell lines derived from digestive tract" International Journal of Oncology. 8. 283-287 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Hiroyuki Sekiguchi, Ken-ichi Isobe, Seiji Akiyama, Hong Yi, Hiroki Takeshita, Tadashi Watanabe, Yasushi Kasai, Katsuki Ito, Yumi Kanegae, Izumu Saito, Izumi Nakashima and Hiroshi Takagi: "Efficient adenovirus-mediated gene transfer into human cancer cell lines derived from digestive tract." International Journal of Oncology. 8. 283-287 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Hiroyuki Sekiguchi: "Efficient adenovirus-mediated gene transfer into human cancer cell lines derived from digestive tract" International Journal of Oncology. 8. 283-287 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] HIROYUKI SEKIGUCHI: "Efficient adenovirus-mediated gene transfer into human cancer cell lines derived from digestive tract" International Journal of Oncology. 8. 283-287 (1996)

    • Related Report
      1995 Annual Research Report

URL: 

Published: 1995-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi